Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study-Reference-Cited by-同舟云学术

Tofacitinib is an effective treatment for moderate to severe ulcerative colitis, and intestinal ultrasound can discriminate response from non-response: a pragmatic prospective real-world study

Published:2024-05-30 Issue:1 Volume:56 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Ollech Jacob E.¹,Eran-Banai Hagar¹,Goren Idan²,Sharar Fischler Tali¹,Avni-Biron Irit¹,Snir Yifat¹,Broitman Yelena¹,Cohen Shaked¹,Friedenberg Adi¹,Pauker Maor H.¹,Dotan Iris¹,Yanai Henit¹

Affiliation:

1. Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

2. Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic, OH, U.S.A

Funder

Pfizer

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2024.2358183

Reference22 articles.

1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

2. Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

3. ACG Clinical Guideline: Ulcerative Colitis in Adults

4. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

5. Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research;Journal of Clinical Medicine;2024-08-01